CRLBFCRLBFOTC

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Latest News

marijuanastocks.com

March 2026 Cannabis Stock Watchlist: High-Risk, High-Reward MSOs

The U.S. cannabis industry continues evolving as March 2026 begins. Although volatility remains, long-term growth trends still attract investors. Legal cannabis sales in the United States now exceed $30 billion annually. Furthermore, analysts project steady expansion over the next several years. State legalization continues to spread, while federal reform discussions remain active. Therefore, multi-state operators are positioning for the next growth phase.

marijuanastocks.com

3 Top Marijuana Stocks to Watch Before March 2026

The U.S. cannabis industry continues evolving as 2026 approaches. Growth remains uneven, yet opportunity still exists. Several operators are focusing on efficiency and profitability. Meanwhile, investors are watching for progress on federal reform. Rescheduling discussions has improved overall sentiment. However, capital access remains limited for many companies.

businesswire.com

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide.

marijuanastocks.com

3 Marijuana Stocks To Help You Become Profitable

The cannabis industry continues to evolve rapidly, creating both opportunity and volatility for marijuana stocks. For investors seeking to achieve profitability in this sector, education is the first and most crucial step. Understanding how the cannabis industry operates can dramatically improve decision-making and long-term returns. The foundation begins with regulation. Cannabis remains federally illegal, although it has recently been rescheduled in the United States. Yet it's legal in many states, creating a complex legal environment that directly impacts marijuana stocks.

zacks.com

New Strong Sell Stocks for February 9th

GPRE, CRLBF and BSET have been added to the Zacks Rank #5 (Strong Sell) List on February 9, 2026.

marijuanastocks.com

U.S. Marijuana Stocks to Watch as the Industry Enters 2026

The U.S. cannabis sector continues to evolve as 2026 begins, creating both risk and opportunity for investors. After years of regulatory uncertainty, many operators are now focused on efficiency, balance sheet repair, and selective growth. Meanwhile, potential federal reform remains a major catalyst that could reshape valuations across the industry. As a result, investors are becoming more selective when building watchlists.

marijuanastocks.com

Here Are 3 Marijuana Stocks For Investors 2026

Marijuana stock investors are keeping focused on what's next to come as the industry is still changing. 2026 is already off to a strong start, with more regions expanding their operations globally. The Canadian cannabis market is experiencing significant growth, and companies are collaborating to progress the industry. Europe has a market that is also growing and expanding beyond tourism. With the USA being the biggest of them all, investors have a lot to focus on.

marijuanastocks.com

Best Marijuana Penny Stocks for January 2026: High-Risk, High-Reward Plays

U.S. marijuana penny stocks can deliver sharp moves in short periods. That volatility creates opportunity, but it also raises risk. Therefore, focusing on operators with real assets and retail exposure matters. Companies with dispensaries, production, and brand recognition often hold attention longer. As January 2026 begins, these three names stand out for different reasons.

marijuanastocks.com

Top Cannabis Stocks in the U.S. Heading Into January 2026

The U.S. cannabis sector continues to evolve as regulatory momentum slowly builds. Although volatility remains, strong operators are positioning for long-term growth. As January 2026 begins, investors are watching companies with scale, brand power, and improving financial discipline. Three names continue to stand out among U.S. multistate operators. These include Trulieve Cannabis Corp., Curaleaf Holdings, Inc., and Cresco Labs Inc. Each company combines retail reach with operational experience. As a result, they remain key stocks to monitor in the new year.

businesswire.com

Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Tamarac, located at 6001 N University Drive in Tamarac, Fla. It is the Company's 31st dispensary in Florida and 72nd nationwide. “Florida is the largest medical market in the country, and opening Sunnyside Tamarac reinforces our long-term commitment to serving patients across the state,” said Charlie Bachtell, CEO of Cresco Labs. “We're.

marijuanastocks.com

Top Marijuana Stocks To Buy In 2026 That Could See Big Gains

Investing in an industry that operates in a gray area can hold inherent risk. Yet, the long-term returns may prove to be worth it given the circumstances. For most people who have or are looking to invest in legal cannabis feel this same way. Right now, most marijuana stock investors are feeling the impact of the sector. Whether seasoned or new to the world of cannabis investing, 2026 could be the year where big gains are made. Now that cannabis is officially a scheduled 3 substance, there is more to be done with the plant that couldn't be before.

businesswire.com

Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump's action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. “Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, ackn.

fastcompany.com

Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?

Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.

marijuanastocks.com

3 Marijuana Stocks For Your 2026 Watchlist

Marijuana stocks offer value in the short and long term. So, for the short term, with how low prices are, it's a moment in time to find the best marijuana stocks to buy. Especially before the new year begins, as there could be many factors that impact the market. The long-term value will be based on the progress and success of the cannabis industry. If companies that are publicly traded can maintain stability and consistency as a business, it can help boost their stock price.

marijuanastocks.com

U.S. Marijuana Stocks Positioned for Growth as Reform Discussions Continue

The U.S. cannabis industry is approaching a potentially important inflection point before 2026. Federal policy discussions are continuing to gain momentum behind the scenes. Most notably, cannabis rescheduling remains under active federal review. A move to Schedule III could significantly reduce tax burdens for operators. As a result, profitability and free cash flow could improve quickly. This potential shift has renewed investor interest across the sector.

marijuanastocks.com

These Marijuana Stocks Could Make You Money In 2026

In 2026, marijuana stocks could see a rise in trading throughout different parts of the year. Often, when a strong catalyst moves in the industry, it also moves marijuana stocks. Now, where that market movement is up or down depends on what causes it. So, for example, when quarterly earnings look good or reform measures are being pushed, it helps cannabis stocks. The more positive speculation that circulates, the better the odds of seeing a rise in trading.

marijuanastocks.com

3 Top Marijuana Stocks To Watch This Year

The best way to invest in top marijuana stocks is to know how to prepare. If you can learn and build a strategy that leverages high-volatility cannabis stock investing, it could make you money. 2026 is looking like it will be yet another uphill climb, leading to more pivotal moments. All of which will play a factor in how marijuana stocks trade.

marijuanastocks.com

3 U.S. Cannabis Leaders to Watch in November 2025

The U.S. cannabis market continues to evolve quickly as investors search for strong opportunities heading into late 2025. The industry has expanded significantly during the past few years, and it now generates billions in annual revenue. Many states continue to experience steady growth in both medical and adult-use sales. In addition, consumer interest remains high even during broader market volatility. Because of this consistent demand, leading multistate operators continue to strengthen their national presence. However, the sector still moves cautiously, especially with federal reform remaining uncertain. Even so, several companies continue to separate themselves through scale, branding, and strong operational discipline.

zacks.com

TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?

Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.

zacks.com

Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?

CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance